ALLK

Allakos (ALLK)

Allakos Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALLK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	06 : 09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALLK	Allakos Inc
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/05/10	05 : 02	GlobeNewswire Inc.	Allakos Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:ALLK	Allakos Inc
2024/03/15	05 : 02	GlobeNewswire Inc.	Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:ALLK	Allakos Inc
2024/03/07	08 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/03/07	08 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/03/06	06 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALLK	Allakos Inc
2024/03/05	07 : 52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALLK	Allakos Inc
2024/02/26	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/02/26	21 : 02	GlobeNewswire Inc.	Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024	NASDAQ:ALLK	Allakos Inc
2024/02/22	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/22	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/22	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/17	09 : 08	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/15	06 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/02/14	22 : 34	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/02/12	21 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/02/12	21 : 02	GlobeNewswire Inc.	Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition	NASDAQ:ALLK	Allakos Inc
2024/02/03	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/02/03	02 : 31	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/01/27	06 : 20	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ALLK	Allakos Inc
2024/01/26	23 : 21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/01/17	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/01/16	21 : 02	GlobeNewswire Inc.	Allakos Announces a Restructuring to Focus on Development of AK006	NASDAQ:ALLK	Allakos Inc
2024/01/16	21 : 00	GlobeNewswire Inc.	Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints	NASDAQ:ALLK	Allakos Inc
2024/01/06	06 : 02	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALLK	Allakos Inc
2023/12/06	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2023/12/06	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2023/12/06	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2023/12/05	05 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALLK	Allakos Inc